Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Members of Kenya-led security mission in Haiti were involved in rapes, U.N. says - 2Danish warship sunk by famed British admiral discovered after 225 years
- 3Change Your Physical make-up: Compelling Activities for Muscle Building
- 4Electric Vehicles for Eco-Accommodating Driving
- 5Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Europe could get 42 more days of summer by the year 2100 due to climate change
- Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- Germany ready to assist Syria's reconstruction, says foreign minister
- Bestselling author Colleen Hoover reveals cancer journey
- NASA’s Artemis II mission will take an astronaut crew around the Moon – a space policy expert describes the long road to launch
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- 3D Printers for Specialists
